Sign in

Private company

BODY & MIND INC.

BODY & MIND INC. is a multi-state cannabis operator.1 It is headquartered in Vancouver, Canada.1

Last updated Oct 21, 2026.

Overview

$22.8MRevenue, fiscal 20232
-$20.6MNet income, fiscal 20232
  • IndustryPharmaceutical Preparations1
  • HeadquartersVancouver, Canada1
  • Incorporated inNV3
  • Business address750 - 1095 West Pender Street, Vancouver, A1 V6E 2M63
  • Filer category, Emerging growth company3
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Body and Mind is a multi-state cannabis operator, which has retail, distribution, cultivation, and/or processing operations in Nevada, California, Arkansas, Ohio and Illinois. The company is also engaged in the development of retail licenses in Illinois and New Jersey.5 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

25.3%Gross margin2
-33.6%Operating margin2
-90.1%Net margin2
-2.4%Revenue growth, 20232
-$4.8MFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue75¢$17.0M
  • Other costs16¢$3.6M
  • Income tax10¢$2.2M

Out of $22.8M in revenue.2 The company lost money this year.

Financial statements

Revenue67892$22.8M in 2023+747% since 2018
0$10.0M$20.0M$30.0M2018: $2.7M$2.7M20182019: $5.3M$5.3M2019+98%2020: $6.2M$6.2M2020+17%2021: $26.9M$26.9M2021+332%2022: $23.4M$23.4M2022−13%2023: $22.8M$22.8M2023−2%
Gross profit67892$5.8M in 2023+383% since 2018
0$5.0M$10.0M$15.0M2018: $1.2M$1.2M20182019: $1.8M$1.8M2019+49%2020: $1.5M$1.5M2020−15%2021: $12.0M$12.0M2021+695%2022: $7.4M$7.4M2022−38%2023: $5.8M$5.8M2023−22%
Operating income792-$7.7M in 2023+170% since 2019
-$10.0M-$7.5M-$5.0M-$2.5M0$2.5M2019: -$2.8M-$2.8M20192020: -$5.5M-$5.5M2020+95%2021: $587.3K$587.3K20212022: -$4.5M-$4.5M20222023: -$7.7M-$7.7M2023+70%
Net income1067892-$20.6M in 2023+5501% since 2017
-$30.0M-$20.0M-$10.0M02017: -$367.2K-$367.2K20172018: -$1.8M-$1.8M2018+385%2019: -$3.8M-$3.8M2019+111%2020: -$4.6M-$4.6M2020+23%2021: -$2.0M-$2.0M2021−57%2022: -$28.2M-$28.2M2022+1328%2023: -$20.6M-$20.6M2023−27%
Fiscal year20162017201820192020202120222023
Revenue$2.7M6$5.3M7$6.2M8$26.9M9$23.4M2$22.8M2
Cost of revenue-$1.2M6-$2.8M6$3.8M8$13.7M8$15.9M2$17.0M2
Gross profit$1.2M6$1.8M7$1.5M8$12.0M9$7.4M2$5.8M2
Operating expenses$12.0M2$13.4M2
Operating income-$2.8M7-$5.5M7$587.3K9-$4.5M2-$7.7M2
Interest$277.2K6$1.2M7$132.7K8$53.4K9$1.4M9
Income before tax-$26.6M2-$18.2M2
Income tax-$239.4K6$07$134.2K8$2.2M9-$1.8M2-$2.2M2
Net income-$367.2K10-$1.8M6-$3.8M7-$4.6M8-$2.0M9-$28.2M2-$20.6M2

Compare BODY & MIND INC. with another company

Corporate structure

BODY & MIND INC. sits at the top of its group. 17 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of BODY & MIND INC.

  • BODY & MIND INC. Vancouver, Canada
    • BaM Body and Mind Dispensary NJ, Inc. Subsidiary · New Jersey, United States
    • Canopy Monterey Bay, LLC Subsidiary · California, United States
    • DEP Nevada Inc. Subsidiary · Nevada, United States
    • Nevada Medical Group, LLC Subsidiary · Nevada, United States
    • NMG CA C1, LLC Subsidiary · California, United States
    • NMG CA P1, LLC Subsidiary · California, United States
    • NMG Cathedral City, LLC Subsidiary · California, United States
    • NMG IL 4, LLC Subsidiary · Illinois, United States
    • NMG Long Beach, LLC Subsidiary · California, United States
    • NMG MI 1, Inc. Subsidiary · Michigan, United States
    • NMG MI C1 Inc Subsidiary · Michigan, United States
    • NMG MI P1 Inc . Subsidiary · Michigan, United States
    • NMG OH 1, LLC Subsidiary · Ohio, United States
    • NMG OH P1, LLC Subsidiary · Ohio, United States
    • NMG Ohio LLC Subsidiary · Ohio, United States
    • NMG San Diego, LLC Subsidiary · California, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What BODY & MIND INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$8.3M9 Jul 31, 2022$6.6M9 Jul 31, 2021+26.0%
Accumulated depreciation$2.7M9 Jul 31, 2022$1.7M9 Jul 31, 2021+56.9%
Property and equipment, net$1.8M2 Jul 31, 2023$3.7M2 Jul 31, 2022−50.9%
Operating-lease assets (leased space)$4.3M2 Jul 31, 2023$3.3M2 Jul 31, 2022+32.3%

Investments

ItemLatestA year beforeChange
Deposits held (banks)$113.8K9 Jul 31, 2022

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$09 Jul 31, 2022$5.2M9 Jul 31, 2021−100.0%
Finite-lived intangibles, gross$14.3M9 Jul 31, 2022$21.1M9 Jul 31, 2021−31.9%
Accumulated amortization-$2.5M9 Jul 31, 2022-$1.2M9 Jul 31, 2021−105.5%
Finite-lived intangibles, net$3.6M2 Jul 31, 2023$11.4M9 Jul 31, 2022−68.3%

Inventory

ItemLatestA year beforeChange
Inventory, total$2.3M2 Jul 31, 2023$3.6M2 Jul 31, 2022−35.2%
Work in process$652.8K2 Jul 31, 2023$610.0K2 Jul 31, 2022+7.0%
Finished goods$604.5K2 Jul 31, 2023$2.0M2 Jul 31, 2022−69.2%

Leadership

Who has led BODY & MIND INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Leonard Clough2018

President

  1. Leonard Clough2018

Chief financial officer

  1. Darren Tindale2018
  2. Dong Hyun Shim2019–2023

Chief operating officer

  1. Stephen August Hoffman2019–2023
20202025
Board members and other officers (11)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • CEOMichael Mills named Dec 9, 2021 to Nov 15, 202427
  • DirectorJosh Rosen named May 8, 2023 to Nov 15, 202427

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • BaM Body and Mind Dispensary NJ, Inc. New Jersey, USA4
  • Canopy Monterey Bay, LLC California, USA4
  • DEP Nevada Inc. Nevada, USA4
  • NMG CA C1, LLC California, USA4
  • NMG CA P1, LLC California, USA4
  • NMG Cathedral City, LLC California, USA4
  • NMG IL 4, LLC Illinois, USA4
  • NMG Long Beach, LLC California, USA4
  • NMG MI 1, Inc. Michigan, USA4
  • NMG MI C1 Inc Michigan, USA4
  • NMG MI P1 Inc . Michigan, USA4
  • NMG OH 1, LLC Ohio, USA4
  • NMG OH P1, LLC Ohio, USA4
  • NMG Ohio LLC Ohio, USA4
  • NMG San Diego, LLC California, USA4
  • Nevada Medical Group, LLC Nevada, USA4

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • DEPLOY TECHNOLOGIES INCAug 29, 2017 to Aug 29, 20173

Timeline

  1. Sep 4, 20268-K Regulation FD disclosure28
  2. Sep 5, 20258-K Entered a material agreement; Completed an acquisition or sale; Other events29
  3. Aug 13, 20258-K Entered a material agreement; Other events30
  4. Jun 12, 20258-K Entered a material agreement; Completed an acquisition or sale; New debt or obligation31
  5. Apr 23, 20258-K Entered a material agreement; Other events32
  6. Apr 9, 20258-K Entered a material agreement; New debt or obligation; Other events33
  7. Feb 6, 20258-K Earlier financial statements no longer reliable; Other events34
  8. Feb 3, 20258-K Entered a material agreement35
  9. Jan 30, 20258-K Regulation FD disclosure36
  10. Jan 29, 20258-K Executive or director change; Regulation FD disclosure37
  11. Jan 21, 20258-K Other events38
  12. Jan 10, 20258-K Entered a material agreement39
  13. Aug 15, 2018New chief executive Leonard Clough becomes CEO13

Calendar

When it reported results

  1. Jun 21, 2024Reported quarterly or annual results40
  2. Mar 26, 2024Reported quarterly or annual results41
  3. Dec 21, 2023Reported quarterly or annual results42
  4. Nov 14, 2023Reported quarterly or annual results43
  5. Jun 21, 2023Reported quarterly or annual results44
  6. Mar 23, 2023Reported quarterly or annual results45
  7. Jan 25, 2023Reported quarterly or annual results46
  8. Jan 18, 2023Reported quarterly or annual results47

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

141 filings to the SEC since October 2021: 3 annual reports, 9 quarterly reports, 74 major events, 21 insider forms, 3 large holders, 9 private raises, 22 other. The latest 20:

  1. Sep 4, 20268-K EDGAR
  2. Sep 5, 20258-K EDGAR
  3. Aug 13, 20258-K EDGAR
  4. Jun 12, 20258-K EDGAR
  5. Apr 23, 20258-K EDGAR
  6. Apr 9, 20258-K EDGAR
  7. Feb 6, 20258-K EDGAR
  8. Feb 3, 20258-K EDGAR
  9. Jan 30, 20258-K EDGAR
  10. Jan 29, 20258-K EDGAR
  11. Jan 21, 20258-K EDGAR
  12. Jan 10, 20258-K EDGAR
  13. Jan 6, 20258-K EDGAR
  14. Dec 30, 20248-K EDGAR
  15. Dec 13, 20248-K EDGAR
  16. Dec 2, 20248-K EDGAR
  17. Nov 15, 2024D EDGAR
  18. Oct 30, 20248-K EDGAR
  19. Oct 29, 2024NT 10-K EDGAR
  20. Sep 10, 20248-K EDGAR

The 141 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

7 open-market trades by officers, directors and large owners since October 2021: 7 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
May 8, 2023Bengal Impact Partners, LLC10% ownerBuy671,642$0.04$26.9KForm 4
May 4, 2022Hoffman Stephen AugustChief Operating OfficerBuy20,000$0.15$3.0KForm 4
Mar 22, 2022Mills MichaelPresident and CEOBuy109,000$0.24$26.2KForm 4
Feb 3, 2022Hoffman Stephen AugustChief Operating OfficerBuy25,000$0.25$6.2KForm 4
Jan 11, 2022SHIM DONG HYUNChief Financial OfficerBuy16,667$0.36$6.0KForm 4
Dec 23, 2021Mills MichaelPresident and CEOBuy20,000$0.39$7.8KForm 4
Dec 22, 2021Hoffman Stephen AugustChief Operating OfficerBuy20,000$0.28$5.6KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$7.5M 2021–2024
Money received by yearMoney received by year, 2021–2024: $7.5M in all. Private raises (Form D) $7.5M.$0$2M$4M$6M$8M2021 · Private raises (Form D): $998.2K20212022 · Private raises (Form D): $6.2M202220232024 · Private raises (Form D): $278.5K2024
Figures by year
YearPrivate raises (Form D)Total
2024$278.5K$278.5K
2022$6.2M$6.2M
2021$998.2K$998.2K

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Nov 7, 2024Raised $99,965 in a private offering of equity27 Form D: 5 investors so far Form D
  2. Feb 9, 2024Raised $178,527 in a private offering of equity50 Form D: 1 investor so far Form D
  3. Apr 25, 2023Filed a private offering of securities51 Form D: $205,132 offered in all Form D
  4. Dec 21, 2022Raised $979,467 in a private offering of equity52 Form D: 9 investors so far Form D
  5. Dec 19, 2022Raised $3 million in a private offering of equity53 Form D: $4.5 million offered in all Form D
  6. Dec 7, 2022Raised $2.2 million in a private offering of equity54 Form D: 1 investor so far Form D
  7. Jul 15, 2022Raised $75,000 in a private offering of equity55 Form D: 1 investor so far Form D
  8. Jun 14, 2022Filed a private offering of securities56 Form D: $160,000 offered in all Form D
  9. Dec 3, 2021Raised $998,228 in a private offering of equity57 Form D: 1 investor so far Form D

SEC filer profile

How BODY & MIND INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARBODY & MIND INC.1
  • CIK0001715611
  • Employer ID (EIN)98-13192271
  • Filer status<br>emerging growth company1
  • Incorporated inNevada1
  • Fiscal year endsJuly 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address750 - 1095 West Pender Street, Vancouver, A1 V6E 2M61
  • Phone604-376-35671
  • Shares outstanding147,686,393 as of Jun 19, 202412
  • Public float$9.1M as of Jan 31, 20232
  • On EDGAR sinceAug 29, 20171
  • Filings431 in all: 8-K (170), 4 (128), 10-Q (19), 3 (17), D (16), NT 10-Q (14), SC 13D/A (12), NT 10-K (7)1
    All 26 form types

    UPLOAD (7), 10-K (6), DEFA14A (6), DEF 14A (5), SC 13D (4), 10-12G/A (3), 8-K/A (3), CORRESP (3), S-8 (2), 10-12G (1), 10-K/A (1), 10-Q/A (1), 3/A (1), 424B3 (1), ARS (1), EFFECT (1), S-1 (1), S-1/A (1)

  • Latest filingsAnnual report (10-K) Nov 14, 2023
    Quarterly report (10-Q) Jun 20, 2024
    Proxy statement (DEF 14A) Feb 12, 2024
    Latest 8-K (8-K) Sep 4, 2026

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
    SEC EDGAROther events
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57